Critical Path Institute
- Assets
- $26.7m
- Revenue
- $35.3m
- Investments
- $0.0
- Employees
- 176
- Location
- Tucson, AZ
- Founding
- 05/2005
- Data as of
- 06/2023
- EIN
- 20-1991334
Organization Overview
Critical Path Institute is located in Tucson, AZ. The organization was established in 2005. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 06/2023, Critical Path Institute employed 176 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Critical Path Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Critical Path Institute generated $35.3m in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 11.0% each year . All expenses for the organization totaled $32.0m during the year ending 06/2023. While expenses have increased by 10.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Critical Path Institute has awarded 73 individual grants totaling $24,783,217. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
INTERNATIONAL COLLABORATIONS AND NOVEL TOOLS TO ENABLE FASTER DEVELOPMENT OF SAFE MEDICAL PRODUCTS
Describe the Organization's Program Activity:
Part 3 - Line 4a
RARE DISEASE CURES ACCELERATOR-DATA AND ANALYTICS PLATFORM (RDCA-DAP) - SEE SCHEDULE O
CRITICAL PATH INSTITUTE ALSO EXECUTES OTHER PROJECTS AND CONSORTIA IN AREAS INCLUDING THERAPEUTICS FOR THE ATAXIAS, POLYCYSTIC KIDNEY DISORDER, ALZHEIMER'S DISEASE, PARKINSON'S, TB, SICKLE CELL DISEASE, TYPE 1 DIABETES, DUCHENNE MUSCULAR DYSTROPHY, ALPHA-1 ANTITRYPSIN DEFICIENCY, LYSOSOMAL DISEASES, MODEL INFORMED DRUG DEVELOPMENT, PATIENT-REPORTED OUTCOME, ELECTRONIC CLINICAL OUTCOME ASSESSMENT, RARE DISEASE CLINICAL OUTCOME ASSESSMENT, TRANSPLANT THERAPEUTICS, PREDICTIVE SAFETY TESTING, PEDIATRICS, AND OTHERS.
CURE DRUG REPURPOSING COLLABORATORY (CDRC) - SEE SCHEDULE O
CRITICAL PATH FOR RARE NEURODEGENERATIVE DISEASES (CP-RND) - SEE SCHEDULE O
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Ms Kristen Swingle COO & President | Officer | 40 | $310,147 |
Dr Klaus Romero Chief Science Officer | Officer | 40 | $241,799 |
Mr Kevin Perkins Chief Financial Officer & Treasurer | Officer | 40 | $236,942 |
Mr Richard Liwski Chief Technology Officer | Officer | 40 | $226,150 |
Dr Stephen Coons Senior Vice President Thru 03/31/23 | Officer | 40 | $224,167 |
Dr Sudhir Sivakumaran Vice President/executive Director | Officer | 40 | $208,819 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Aridhia Informatics Limited It Services | 6/29/23 | $726,962 |
Replica Analytics Ltd Consultant | 6/29/23 | $297,070 |
Lotos Nile Public Relations | 6/29/23 | $254,344 |
Pharmascouts Consultant | 6/29/23 | $174,000 |
Maryna Kolochavina Consultant | 6/29/23 | $166,988 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $18,935,171 |
| All other contributions, gifts, grants, and similar amounts not included above | $4,621,865 |
| Noncash contributions included in lines 1a–1f | $32,192 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $23,557,036 |
| Total Program Service Revenue | $11,292,408 |
| Investment income | $403,834 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $35,267,282 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $4,116,598 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $506,606 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,549,216 |
| Compensation of current officers, directors, key employees. | $1,127,757 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $13,659,070 |
| Pension plan accruals and contributions | $950,723 |
| Other employee benefits | $1,186,216 |
| Payroll taxes | $1,126,088 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $52,818 |
| Fees for services: Accounting | $71,025 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $2,758,957 |
| Advertising and promotion | $329,465 |
| Office expenses | $347,789 |
| Information technology | $1,756,423 |
| Royalties | $0 |
| Occupancy | $526,615 |
| Travel | $698,989 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $1,070,950 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $30,852 |
| Insurance | $102,970 |
| All other expenses | $0 |
| Total functional expenses | $32,008,378 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,343,137 |
| Savings and temporary cash investments | $18,603,787 |
| Pledges and grants receivable | $2,673,874 |
| Accounts receivable, net | $1,595,768 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $100,962 |
| Net Land, buildings, and equipment | $41,740 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $2,367,377 |
| Total assets | $26,726,645 |
| Accounts payable and accrued expenses | $2,558,542 |
| Grants payable | $0 |
| Deferred revenue | $6,796,932 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $2,105,301 |
| Total liabilities | $11,460,775 |
| Net assets without donor restrictions | $15,265,870 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $26,726,645 |
Grants Awarded
Over the last fiscal year, Critical Path Institute has awarded $4,116,598 in support to 12 organizations.
| Grant Recipient | Amount |
|---|---|
NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD) PURPOSE: SUBAWARD | $1,517,664 |
JAEB CENTER FOR HEALTH RESEARCH PURPOSE: SUBAWARD | $14,789 |
TUFTS MEDICAL CENTER INC PURPOSE: SUBAWARD | $86,009 |
INSTITUTE FOR ADVANCED CLINICAL TRIALS FOR CHILDREN PURPOSE: SUBAWARD | $77,657 |
NORTHWESTERN UNIVERSITY PURPOSE: SUBAWARD | $54,297 |
SOCIETY OF CRITICAL CARE MEDICINE PURPOSE: SUBAWARD | $1,377,667 |